Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy. A Report From the North American ARVC Registry

Journal of the American College of Cardiology

Volumn 54, Issue 7, 2009, Pages 609-615

  Marcus, Gregory M ^a   Glidden, David V ^b   Polonsky, Bronislava ^c   Zareba, Wojciech ^c   Smith, Lisa M ^a   Cannom, David S ^d   Estes III, N A Mark ^e   Marcus, Frank ^f   Scheinman, Melvin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d GOOD SAMARITAN HOSPITAL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

antiarrhythmic drugs; ARVC; ARVD; ICD; ventricular arrhythmias

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; SOTALOL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATOR; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART PROTECTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SHOCK;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SOTALOL; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 67849085428     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.052     Document Type: Article

References (10)

1. Thiene G., and Basso C. Arrhythmogenic right ventricular cardiomyopathy: an update. Cardiovasc Pathol 10 (2001) 109-117
2. Kies P., Bootsma M., Bax J., Schalij M.J., and van der Wall E.E. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm 3 (2006) 225-234
3. Calkins H. Arrhythmogenic right-ventricular dysplasia/cardiomyopathy. Curr Opin Cardiol 21 (2006) 55-63
4. Marcus F.I., Fontaine G.H., Frank R., Gallagher J.J., and Reiter M.J. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J 10 Suppl D (1989) D68-D73
5. Wichter T., Borggrefe M., Haverkamp W., Chen X., and Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 86 (1992) 29-37
6. McKenna W.J., Thiene G., Nava A., et al., Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71 (1994) 215-218
7. Fisher L.D., and Lin D.Y. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20 (1999) 145-157
8. Cook R.J., and Lawless J.F. Analysis of repeated events. Stat Methods Med Res 11 (2002) 141-166
9. Wichter T., Paul T.M., Eckardt L., et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?. Herz 30 (2005) 91-101
10. Sen-Chowdhry S., Lowe M.D., Sporton S.C., and McKenna W.J. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 117 (2004) 685-695